Olympus 2012 Annual Report Download - page 95

Download and view the complete annual report

Please find page 95 of the 2012 Olympus annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 105

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105

“Others” business manufactures and sells biomedical materials, conducts system development and other business activities.
(2) Method of calculating amounts of net sales, profit/loss, assets, and other items
The accounting policies of the segments are basically the same as those described in the significant accounting policies in Note 1. Segment profit or loss corresponds to operating
income on the consolidated statement of operations. The internal sales or transfer among segments are based on actual market prices.
(3) Information concerning net sales and profit (loss), assets and other items by reportable segment
Millions of yen
2012
Medical
Life Science
and Industrial Imaging
Information
and Communi-
cation Others Total Adjustments
Consolidated
Total
Net sales:
Third parties ....................... ¥ 349,246 ¥ 92,432 ¥ 128,561 ¥ 229,399 ¥ 48,910 ¥ 848,548 ¥ — ¥ 848,548
Intersegment ...................... 158 16 84 — 142 400 (400) —
Total ..................................... 349,404 92,448 128,645 229,399 49,052 848,948 (400) 848,548
Segment profit (loss) ............ 68,188 5,439 (10,760) 5,277 (7,992) 60,152 (24,634) 35,518
Assets .................................. 462,317 79,251 88,928 98,842 73,207 802,545 163,981 966,526
Depreciation and amortization .. 17,935 3,606 4,696 1,029 1,891 29,157 4,630 33,787
Amortization of goodwill ........ 6,695 664 — 2,890 2,034 12,283 — 12,283
Capital expenditures .............. ¥ 15,588 ¥ 4,292 ¥ 5,211 ¥ 666 ¥ 5,735 ¥ 31,492 ¥ 6,469 ¥ 37,961
Millions of yen
2011
Medical
Life Science
and Industrial Imaging
Information
and Communi-
cation Others Total Adjustments
Consolidated
Total
Net sales:
Third parties ....................... ¥ 355,322 ¥ 100,808 ¥ 131,417 ¥ 209,520 ¥ 50,038 ¥ 847,105 ¥ — ¥ 847,105
Intersegment ...................... 135 170 91 — 43 439 (439) —
Total ..................................... 355,457 100,978 131,508 209,520 50,081 847,544 (439) 847,105
Segment profit (loss) ............. 71,682 8,553 (15,019) 5,242 (3,606) 66,852 (28,472) 38,379
Assets .................................. 436,586 84,773 107,679 93,261 76,967 799,266 219,894 1,019,160
Depreciation and amortization .. 16,913 4,395 6,021 577 2,057 29,963 4,225 34,188
Amortization of goodwill ........ 6,935 922 — 2,448 1,944 12,249 — 12,249
Capital expenditures .............. ¥ 15,525 ¥ 3,913 ¥ 4,838 ¥ 738 ¥ 3,685 ¥ 28,699 ¥ 4,000 ¥ 32,699
Thousands of U.S.dollars
2012
Medical
Life Science
and Industrial Imaging
Information
and Communi-
cation Others Total Adjustments
Consolidated
Total
Net sales:
Third parties ....................... $ 4,365,575 $ 1,155,400 $ 1,607,013 $ 2,867,488 $ 611,374 $ 10,606,850 $ — $ 10,606,850
Intersegment ...................... 1,975 200 1,050 — 1,775 5,000 (5,000) —
Total ..................................... 4,367,550 1,155,600 1,608,063 2,867,488 613,149 10,611,850 (5,000) 10,606,850
Segment profit (loss) ............. 852,350 67,988 (134,500) 65,963 (99,901) 751,900 (307,925) 443,975
Assets .................................. 5,778,963 990,638 1,111,600 1,235,525 915,087 10,031,813 2,049,762 12,081,575
Depreciation and amortization .. 224,188 45,075 58,700 12,863 23,637 364,463 57,875 422,338
Amortization of goodwill ........ 83,688 8,300 — 36,125 25,425 153,538 — 153,538
Capital expenditures .............. $ 194,850 $ 53,650 $ 65,138 $ 8,325 $ 71,687 $ 393,650 $ 80,863 $ 474,513
Notes : 1. Segment profit (loss) is adjusted to agree with operating income on the consolidated statements of operations.
2. Adjustments for segment profit and loss include ¥(24,634) million ($(307,925) thousand) and ¥(28,472) million for the years ended March 31, 2012 and 2011, respectively, of corporate general administration and research and
development center expenses, which are not allocable to the reportable segments.
3. Adjustments for segment assets include ¥163,981 million ($2,049,762 thousand) and ¥219,894 million as of March 31, 2012 and 2011, respectively, of corporate assets.
4. Adjustments for depreciation and amortization include ¥4,630 million ($57,875 thousand) and ¥4,225 million for the years ended March 31, 2012 and 2011, respectively, of depreciation and amortization for corporate assets, which
are not allocable to the reportable segments.
5. Adjustments for capital expenditures include ¥6,469 million ($80,863 thousand) and ¥4,000 million for the years ended March 31, 2012 and 2011, respectively, of the increase in property, plant and equipment and intangible
assets, which are not allocable to the reportable segments.
OLYMPUS 󱚈 Annual Report 2012 93